Cibc World Markets Corp Catalyst Pharmaceuticals, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 14,265 shares of CPRX stock, worth $305,841. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,265
Previous 25,074
43.11%
Holding current value
$305,841
Previous $608,000
49.18%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CPRX
# of Institutions
387Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$401 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$188 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$117 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$69.7 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$68.3 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.2B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...